Testing earlier screening for gestational diabetes in early pregnancy
Tests whether screening for gestational diabetes in the first trimester is workable and acceptable.
Key facts
- Who runs it
- University of Massachusetts, Worcester
- Where
- Worcester, United StatesSee the site
- Trial code
- Registry title
- Early Detection of Gestational Diabetes Mellitus in Pregnancy
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 1 Jul 2025
- Expected to end
- 1 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Enhanced First Trimester GDM Screening
- Routine Gestational Diabetes Screening
- Record updated
- 6 April 2026
Who can take part
The trial is looking for pregnant women early in pregnancy who are at high risk of diabetes during pregnancy (gestational diabetes). It tests early blood sugar screening in the first trimester.
- Age
- 18 years or older.
- Sex
- Women only.
- Disease stage
- Pregnant with one baby, 12 weeks or less at the first pregnancy visit. High risk of gestational diabetes by ACOG clinical risk factor guidelines. Must get pregnancy care and plan to give birth at UMMHC. Must speak English or Spanish.
- Main reasons for not taking part
- Diabetes known from before the pregnancy
- Plans to get pregnancy care or give birth outside UMMHC
- Unable to complete an oral glucose tolerance test, for example after gastric bypass surgery, dumping syndrome or vomiting the test drink
- Use of steroid medicines that act on the whole body
This trial only enrols pregnant participants. The registry sentence this rests on: * 2) singleton gestation less than or equal to 12 weeks at initial obstetric visit,
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- 1) age greater than or equal to 18 years old,
- 2) singleton gestation less than or equal to 12 weeks at initial obstetric visit,
- 3) receiving prenatal care at UMMHC and plans to deliver at UMMHC,
- 4) able and willing to provide informed consent,
- 5) English or Spanish speaking, and
- 6) are at high risk for developing GDM by ACOG clinical risk factor guidelines
Who cannot take part
- 4) systemic steroid use
- 1) known diagnosis of pre-existing pregestational diabetes,
- 3) inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test), or
- 2) plan to receive prenatal care or deliver outside of UMMHC,
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Gestational diabetes mellitus in pregnancy
This trial is currently available in United States.
- University of Massachusetts Memorial Medical CenterWorcester, United StatesContact: Gianna L Wilkie, MDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to develop an implementation protocol and test the feasibility and acceptability of a first trimester screening protocol for the early detection of gestational diabetes mellitus (GDM).
The 2 groups in the trial
- Enhanced First Trimester GDM ScreeningTreatment being tested
Women who are randomly assigned to this condition will be required to have early glucose screening with a prediction model composed of additional clinical risk factors and serum biomarkers (triglycerides, PAPP-A, and lipocalin-2) with their initial prenatal laboratory assessment.
- Standard of Care GDM ScreeningExisting treatment, for comparison
Women who will be randomized to the comparison condition of usual standard of care will undergo routine standard of care. The standard of care will consist of routine screening for diabetes in pregnancy between 24 to 28 weeks of gestation via the two-step screening method with possible early screening with either plasma fasting glucose, oral glucose tolerance test, or hemoglobin A1c at the providers discretion to represent true clinical practice.
Treatment: Routine Gestational Diabetes Screening
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early Detection of Gestational Diabetes Mellitus in Pregnancy: A Randomized Trial
- Plain-language title
- Testing earlier screening for gestational diabetes in early pregnancyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT05388643, who can take part
- Record updated
- 6 April 2026